(LifeSiteNews) — Pfizer CEO Albert Bourla said he believes life will “return to normal” as his company develops a new version of its abortion-tainted and leaky COVID vaccine and sells its new treatment to countries.
He told French publication Le Figaro on Sunday that society could “resume a normal life” soon.
All it will require is that at least once a year you trudge off to the local pharmacy or hospital and get jabbed with the Pfizer vaccine.
Bourla said COVID will be “very difficult to eradicate” and could be around “for years,” according to Midi Libre. Lucky for you (if you own Pfizer stock), he’ll have a shot for you.
Conveniently, Pfizer is developing a jab that works against the Omicron variant.
And if I were a betting man, I’d guess Pfizer’s scientists are working on a 2023 Rho vaccine and a Sigma shot for 2024.
“It has spread all over the world, it can infect the same person several times, and it has mutated to the point of making us rediscover the Greek alphabet,” Bourla said.
“The question is not whether this virus will disappear or not … [it] is: are we going to be able to resume a normal life?”
Bourla said he believes you will … if you take his shots.
“We are well positioned to get there in the spring thanks to all the tools at our disposal: tests, very effective vaccines, and the first treatments that can be taken at home,” he said.
The “effective vaccines” must be taken at least once a year, according to Bourla’s past statements. Those “treatments” of course refer to Pfizer’s own preparations, not cheap and widely-tested options like ivermectin or hydroxychloroquine.
“The most likely scenario for me is that, because the virus is spread all over the world, that [we] will continue seeing new variants that are coming out,” Bourla predicted in September 2021.
One reason that the virus may continue to spread despite the availability of a vaccine for over a year now, is that the jabs are not effective at stopping transmission.
“Our vaccines are working exceptionally well. They continue to work well with Delta with regard to severe illness and death,” Centers for Disease Control and Prevention Director Walensky told CNN. “But what they can’t do anymore is prevent transmission.”
Trials on the COVID shots have never produced evidence that the vaccines stop infection or transmission. Success isn’t even measured by stopping transmission but by preventing severe symptoms of COVID-19 disease.
“Also, we will have vaccines that they will last at least a year, and I think the most likely scenario is annual vaccination, but we don’t know really, we need to wait and see the data,” Bourla told ABC News.
“Data” presumably refers to the profit margin and the willingness of governments to keep buying Pfizer shots.
IKEA, the retail furniture giant, has announced that it will CUT sick pay for unvaccinated employees who are forced to quarantine after being exposed to Covid-19 in the United Kingdom!
That's right: In the ongoing global effort to discriminate against unvaccinated people, massive corporations like IKEA are taking things to the next level, and planning to deprive working people of the pay they're entitled to simply because of their vaccination status!
That's why we're asking you to SIGN and SHARE this petition calling on IKEA's executive leadership to discontinue any unfair policies that target unvaccinated workers and threaten them with reduced pay, or face a worldwide boycott of their stores and products.
This new policy will strip unvaccinated IKEA employees who have come in contact with someone who's tested positive for Covid-19 and, therefore, forced to isolate themselves, from well over half of their normal sick pay.
According to a report from Daily Mail, IKEA workers in the U.K. make, on average, between £404 and £452 per week. However, under the corporation's ridiculous new Covid policy, they can expect to make about £96.35 instead -- just because they've chosen against getting the vaccine.
To be clear: As the Omicron variant continues to rise, it's become more and more obvious that the Covid-19 vaccine is largely ineffective at preventing transmission and infection of the virus.
And it also goes without saying that everyone, everywhere should be able to opt against getting this experimental shot -- be it for medical, ethical, faith-based, or simply personal reasons -- without it affecting their ability to make a living and provide for their families.
But, as things currently stand, it would appear that IKEA executives disagree.
While the company has tried to sugar-coat the new policy to the best of their abilities, claiming that "this is an emotive topic and all circumstances will be considered on a case by case basis," the fact remains that any such policy seeks to penalize workers for being unvaccinated -- plain and simple.
And it's obvious where things are headed should this policy stay in place: Affected employees will inevitably opt against disclosing any known contact with a Covid-positive person in order to avoid unfairly losing their pay.
Regardless, this is unacceptable and IKEA must rethink things going forward.
So let's let them know where WE stand, and that, until they revoke this misguided, discriminatory pay policy, we will NOT continue to patronize their company or use their products any longer.
So please SIGN and SHARE this petition calling on IKEA's leadership to abandon this policy (and any future policies) that would, in any way, discriminate against employees in the U.K. for choosing against getting vaccinated for Covid-19.
It shouldn't be any multi-billion-dollar corporation's responsibility or prerogative to withhold pay from their workers just because they've chosen to retain the basic right to make important medical decisions for themselves without undue influence or coercion.
IKEA has let us know how they feel. Now it's time to share with them how we feel.
FOR MORE INFORMATION:
'Retail giant Ikea will drastically cut sick pay of unvaccinated UK employees': https://www.lifesitenews.com/news/retail-giant-ikea-will-drastically-cut-sick-pay-of-unvaccinated-uk-employees/
**Photo Credit: Shutterstock
Pfizer could bring in over $100 billion in revenue in 2022, analyst says
The ongoing fear of COVID, which will include boosters in people as young as five years old, will likely financially benefit Bourla and his company, which could make over $100 billion in revenue in 2022, according to a financial analyst.
According to Markets Insider’s summary, analyst Geoffrey Porges predicted that “Pfizer’s top line will exceed $100 billion in 2022 compared to $82 billion this year, thanks to incremental revenue contributions from Comirnaty and Paxlovid.”
“Universal boosting and pediatric recommendations, the analyst said, should boost COVID-19 vaccine revenue,” Market Insider continued.
“The analyst estimates $59 billion in 2021 COVID vaccine sales and $48 billion in 2022 globally.”
However, Paxlovid, Pfizer’s treatment for a disease which primarily kills elderly people and those with underlying conditions, has numerous restrictions.
It cannot be taken by people with kidney or liver problems. It also cannot be prescribed for people who are hospitalized with COVID and must be taken within three days of symptoms beginning.
The company primarily tested the drug on otherwise healthy people, with only 21% of individuals having a comorbidity.
Johns Hopkins University’s mortality analyses of COVID concluded that 98.5 percent of all individuals who contract COVID will survive. The number includes people of all age groups and medical conditions.
LifeSiteNews has produced an extensive COVID-19 vaccines resources page. View it here.